FindTrial
Sign In

Role of Amalaki Rasayan in Management of Anemia

Clinicopathological Study of Pandu Roga w.s.r to "Soalparaktoalpamedasko Nissarah Shithilendriya"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013339
Enrollment
30
Registered
2018-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients diagnosed with anemia

Interventions

Intervention1: Amalaki Rasayan: Amalaki Rasayan in dose of 6gm OD Morning time empty stomach for 90 days Control Intervention1: not applicable: not applicable

Sponsors

campus director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having classical features of Pandu. 2)Patients with Hb % Concentration less then 12gm/dl(for either sex).

Exclusion criteria

Exclusion criteria: 1)Hb concentration less than 6gm%. 2)Patients having blood dyscrasias e.g Thalassaemias etc. 3)Patients having hemorrhaids, peptic ulcer, malignancy. 4)Patients having hemoglobinopathies e.g sickle cell anaemia, Hb-S disease etc. 5)Pregnant females and lactating mothers. 6)Patients having positive stool investigation report for parasite for the clinical study. 7)Prediagnosed patients of Malabsorption syndrome.

Design outcomes

Primary

MeasureTime frame
The Trail is yet to be startedTimepoint: June 2019—

Secondary

MeasureTime frame
The Trails have not started yetTimepoint: The Work is due to be finished by June 2019—

Countries

India

Contacts

Public ContactRuby Rani Agarwal

Rishikul campus uttarakhand ayurved university

ruby6758@gmail.com9456100745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026